Latest filing published 21 Mar 2018 for Myovant Sciences Ltd., €112.8M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Takeda Pharmaceuticals International AG: trading record in brief
Takeda Pharmaceuticals International AG is a declared insider of Myovant Sciences Ltd., with filings sourced from SEC (Form 4). Between 1 November 2016 and 19 March 2018, the trades on record add up to 8 filings.
Both buying and selling appear: 1 purchase worth €112.8M, against 1 sale worth €112.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 6 option exercises. In 2018 alone, the filings show 1 purchase and 1 sale.
The record was last updated on 21 March 2018 with an open-market purchase (€112.8M) in Myovant Sciences Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 6 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Takeda Pharmaceuticals International AG
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,420,625 shares@ US$18.67100.0% of flowCommon StockSEC:0000899243-18-008309:0
- 4,432 shares0Common SharesSEC:0001209191-17-027447:0
- 6,845 shares0Common SharesSEC:0001209191-17-022833:0
- 13,091 shares0Common SharesSEC:0001209191-17-022833:1
- 22,141 shares0Common SharesSEC:0000904454-17-000243:0
- 5,727 shares0Common SharesSEC:0000904454-17-000243:1
- 1,977,269 shares0Common SharesSEC:0001209191-16-148209:0
7 of 7 declarations
